Login
← Go Back
Viyash Scientific
VIYASH · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in
Stock Price vs Company Growth
1d
1.9%
1w
9.0%
1m
7.0%
3m
5.5%
6m
3.2%
1y
58.1%
5y
4.8%
10y
2.4%
all
1.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 209 1.9%
178
239
Company Overview
Sales
2,126 Cr
Growth: 18.0%
Profit after Tax
76.8 Cr
Growth: -7.4%
Mid Cap
9,133 Cr
P/E: 88.2x
Industry P/E: 27.2x
Fundamentals
Sales (Cr) ₹ 2,126
Growth 18.0%
EBITDA 15.5%
P/S 4.3x
Dividend 0.0%
P/E 88.2x
Book Value ₹ 18.5
PEG Ratio 4.8x
ROE 10.4%
P/B 11.1x
Shareholding Pattern
Institutions
Infinity Holdings
5.91 %
Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii
3.35 %
Ashoka India Opportunities Fund
1.35 %
Sbi Healthcare Opportunities Fund
1.21 %
Mukul Mahavir Agrawal
1.05 %
Promoters
Ca Harbor Investments
53.02 %
Chayadeep Ventures Llp
0.27 %
Rajitha Gopalakrishnan
0.2 %
Sajitha Pillai
0.15 %
Vineetha Mohanakumar Pillai
0.12 %
Others
Increase    Decrease    No change
Company Profile Detailed
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.
Belongs to (11 Indices) view more
Investors (91)
sequent....
dilip.sh...
harish.n...
Followers (7)
jose4
joy2
ratnesh2